Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Debt to Equity (2024 - 2025)

Apellis Pharmaceuticals (APLS) has 2 years of Debt to Equity data on record, last reported at $1.23 in Q4 2025.

  • For Q4 2025, Debt to Equity fell 21.8% year-over-year to $1.23; the TTM value through Dec 2025 reached $1.23, down 21.8%, while the annual FY2025 figure was $1.23, 21.8% down from the prior year.
  • Debt to Equity reached $1.23 in Q4 2025 per APLS's latest filing, up from $1.13 in the prior quarter.
  • Across five years, Debt to Equity topped out at $2.31 in Q2 2025 and bottomed at $1.13 in Q3 2025.